Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma.

Harder, Bryan G; Blomquist, Mylan R; Wang, Junwen; Kim, Anthony J; Woodworth, Graeme F; Winkles, Jeffrey A; Loftus, Joseph C; Tran, Nhan L

Harder, Bryan G; Blomquist, Mylan R; Wang, Junwen; Kim, Anthony J; Woodworth, Graeme F; Winkles, Jeffrey A; Loftus, Joseph C; Tran, Nhan L.

Afiliación

Harder BG; Departments of Cancer Biology and Neurosurgery, Mayo Clinic Arizona, Scottsdale, AZ, United States.
Blomquist MR; Departments of Cancer Biology and Neurosurgery, Mayo Clinic Arizona, Scottsdale, AZ, United States.
Wang J; Department of Health Sciences Research, Center for Individualized Medicine, Mayo Clinic Arizona, Scottsdale, AZ, United States.
Kim AJ; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States.
Woodworth GF; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, United States.
Winkles JA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, United States.
Loftus JC; Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, AZ, United States.
Tran NL; Departments of Cancer Biology and Neurosurgery, Mayo Clinic Arizona, Scottsdale, AZ, United States.

Front Oncol ; 8: 462, 2018.

Article en En | MEDLINE | ID: mdl-30406029

Palabras clave

Blood-brain barrier; GBM; glioblastoma; pharmacotherapy; recurrent GBM; repurposed drugs

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google